Pierfausto Seneci

2.8k total citations
109 papers, 2.0k citations indexed

About

Pierfausto Seneci is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Pierfausto Seneci has authored 109 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 32 papers in Organic Chemistry and 9 papers in Oncology. Recurrent topics in Pierfausto Seneci's work include Chemical Synthesis and Analysis (27 papers), Cell death mechanisms and regulation (21 papers) and RNA Interference and Gene Delivery (12 papers). Pierfausto Seneci is often cited by papers focused on Chemical Synthesis and Analysis (27 papers), Cell death mechanisms and regulation (21 papers) and RNA Interference and Gene Delivery (12 papers). Pierfausto Seneci collaborates with scholars based in Italy, Spain and United Kingdom. Pierfausto Seneci's co-authors include Alfredo Paio, Daniele Lecis, Leonardo Manzoni, Stanislav Miertuš, Eloise Mastrangelo, Daniele Passarella, Giuseppe Faita, Paolo Quadrelli, Carmelo Drago and Domenico Delia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Pierfausto Seneci

98 papers receiving 1.9k citations

Peers

Pierfausto Seneci

PHYSI

PHARM

ONCOL

Luc Demange France

Paul V. Fish United Kingdom

Lora Hamuro United States

Vanessa Soto‐Cerrato Spain

Daniele Marciano Israel

Hyung‐Ho Ha South Korea

Luca Gentilucci Italy

Santosh Rudrawar Australia

Motonari Uesugi Japan

Luc Demange France

Pierfausto Seneci

980 ×0.8

919 ×1.3

214 ×1.1

PHYSI

85 ×0.5

PHARM

248 ×1.7

ONCOL

Citations per year, relative to Pierfausto Seneci Pierfausto Seneci (= 1×) peers Luc Demange

Countries citing papers authored by Pierfausto Seneci

Since Specialization

Citations

This map shows the geographic impact of Pierfausto Seneci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierfausto Seneci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierfausto Seneci more than expected).

Fields of papers citing papers by Pierfausto Seneci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierfausto Seneci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierfausto Seneci. The network helps show where Pierfausto Seneci may publish in the future.

Co-authorship network of co-authors of Pierfausto Seneci

This figure shows the co-authorship network connecting the top 25 collaborators of Pierfausto Seneci. A scholar is included among the top collaborators of Pierfausto Seneci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierfausto Seneci. Pierfausto Seneci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giustini, Alessandro, et al.. (2025). An Inducible Neural Stem Progenitor Cell Model for Testing Therapeutic Interventions Against Neurodegeneration FENIB. Drug Development Research. 86(1). e70041–e70041.

Ferrari, Veronica, Federica Santoro, Michela Bosetti, et al.. (2025). Design, synthesis and characterization of aryl bis-guanyl hydrazones as RNA binders of C9orf72 G4C2 extended repeats. European Journal of Medicinal Chemistry. 293. 117736–117736.

Bonì, Francesco, et al.. (2024). Stabilization of the retromer complex: Analysis of novel binding sites of bis-1,3-phenyl guanylhydrazone 2a to the VPS29/VPS35 interface. Computational and Structural Biotechnology Journal. 23. 1088–1093.

Sesana, Silvia, et al.. (2024). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC Medicinal Chemistry. 16(1). 168–178. 2 indexed citations

Brusco, Simone, Claudia Di Berardino, Eloise Mastrangelo, et al.. (2024). Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth. Scientific Reports. 14(1). 20421–20421. 3 indexed citations

Colombo, Eleonora, Stefania Olla, Cristina Minnelli, et al.. (2023). Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes. Molecules. 28(19). 6928–6928. 2 indexed citations

Saresella, Marina, C Zoia, Francesca La Rosa, et al.. (2023). Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation. Pharmaceuticals. 16(12). 1725–1725. 6 indexed citations

Paolo, Maria Luisa Di, Eleonora Colombo, Laura Polito, et al.. (2023). 2-Hydroxyoleic Acid as a Self-Assembly Inducer for Anti-Cancer Drug-Centered Nanoparticles. Pharmaceuticals. 16(5). 722–722. 3 indexed citations

Mancuso, Roberta, Simone Agostini, Ivana Marventano, et al.. (2023). Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells. Pharmaceuticals. 16(11). 1590–1590. 3 indexed citations

10.

Picciolini, Silvia, Alice Gualerzi, Pierfausto Seneci, et al.. (2023). Raman Spectroscopy Characterization of Multi-Functionalized Liposomes as Drug-Delivery Systems for Neurological Disorders. Nanomaterials. 13(4). 699–699. 14 indexed citations

11.

Donati, Greta, Monica Viviano, Alessandra Cipriano, et al.. (2023). A combined approach of structure‐based virtual screening and NMR to interrupt the PD‐1/PD‐L1 axis: Biphenyl‐benzimidazole containing compounds as novel PD‐L1 inhibitors. Archiv der Pharmazie. 357(3). e2300583–e2300583. 2 indexed citations

12.

Picciolini, Silvia, Alice Gualerzi, Silvia Sesana, et al.. (2023). SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases. The Analyst. 148(23). 6070–6077. 4 indexed citations

13.

Giofrè, Sabrina, Silvia Sesana, Barbara Vergani, et al.. (2022). Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions. Pharmaceutics. 14(11). 2402–2402. 12 indexed citations

14.

Muzio, Luca, Simona Eleuteri, Diego Brancaccio, et al.. (2020). Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis. Nature Communications. 11(1). 3848–3848. 41 indexed citations

15.

Spinelli, Antonello E., M. E. Girelli, Daniela Arosio, et al.. (2019). Intracisternal delivery of PEG-coated gold nanoparticles results in high brain penetrance and long-lasting stability. Journal of Nanobiotechnology. 17(1). 49–49. 28 indexed citations

16.

Manzoni, Leonardo, et al.. (2016). Dual action Smac mimetics–zinc chelators as pro-apoptotic antitumoral agents. Bioorganic & Medicinal Chemistry Letters. 26(19). 4613–4619. 5 indexed citations

17.

Scavullo, Cinzia, Federica Servida, Daniele Lecis, et al.. (2013). Single-agent Smac-mimetic compounds induce apoptosis in B chronic lymphocytic leukaemia (B-CLL). Leukemia Research. 37(7). 809–815. 11 indexed citations

18.

Arosio, Daniela, et al.. (2010). Synthesis of non glycosidic nucleobase-sugar mimetics. Comptes Rendus Chimie. 13(10). 1284–1300. 5 indexed citations

19.

Klafki, Hans‐Wolfgang, Nikolaus Plesnila, Gabriele Hübinger, et al.. (2006). An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proceedings of the National Academy of Sciences. 103(25). 9673–9678. 188 indexed citations

20.

Rabinowitz, Michael H., et al.. (2000). Solid-phase/solution-phase combinatorial synthesis of neuroimmunophilin ligands. Bioorganic & Medicinal Chemistry Letters. 10(10). 1007–1010. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact